SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000873591-02-000041
Filing Date
2002-11-08
Accepted
2002-11-08 15:21:17
Documents
9
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 FORM 10-Q q3200210qbody.htm 10-Q 146182
3 S906 CERTIFICATION ex99_1.htm EX-99.1 1287
4 S906 CERTIFICATION ex99_2.htm EX-99.2 1319
5 SUBLICENSE AGREEMENT ex10_174.htm EX-10 34070
6 STIPULATED SUM AGREEMENT ex10_175.htm EX-10 25657
7 GENERAL CONDITIONS OF THE CONTRACT ex10_176.htm EX-10 23642
8 FIRST AMENDMENT TO US LICENSE AND CO-PROMOTION ex10_177.htm EX-10 10513
9 SECOND AMENDMENT TO FLUMIST SUPPLY AGREEMENT ex10_178.htm EX-10 43855
10 SUPPLY OF FROZEN PRODUCT FOR 2002-03 FLU SEASON ex10_179.htm EX-10 11068
  Complete submission text file 0000873591-02-000041.txt   300130
Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Filer) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14657 | Film No.: 02814144
SIC: 2836 Biological Products, (No Diagnostic Substances)